1. Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity.
- Author
-
Varshney K, Gupta AK, Sonkar R, Varshney S, Mishra A, Bhatia G, Gaikwad A, Srivastava AK, Saxena M, Jain S, and Saxena AK
- Subjects
- 3T3-L1 Cells, Animals, Antioxidants chemical synthesis, Antioxidants chemistry, Blood Glucose drug effects, Cells, Cultured, Humans, Hydrazones chemical synthesis, Hydrazones chemistry, Hydroxyl Radical antagonists & inhibitors, Hypoglycemic Agents chemical synthesis, Hypoglycemic Agents chemistry, Indoles chemical synthesis, Indoles chemistry, Lipoproteins, LDL chemistry, Male, Mice, Oxygen chemistry, Rats, Rats, Sprague-Dawley, Antioxidants therapeutic use, Hydrazones therapeutic use, Hypoglycemic Agents therapeutic use, Indoles therapeutic use, Lipoproteins, LDL therapeutic use
- Abstract
A series of substituted oxopropanylindole hydrazone derivatives was synthesized and evaluated for anti-oxidant and anti-dyslipidemic activity. Of the 12 tested, 3 compounds (6c, 7b and 7d) showed good anti-oxidant activity, compound 6c attenuated LDL oxidation by 32%. The compounds 6c and 7d also showed good anti-dyslipidemic activity by reducing serum levels of total cholesterol (TC), phospholipids (PL) and triglycerides (TG). These two compounds were further evaluated for antiadipogenic and anti-hyperglycemic activity, where 6c showed 44% reduction in lipid accumulation and 20.5% and 24.3% reduction in blood glucose at 5h and 24h respectively, as compared to standard drug metformin. Thus, compounds 6c and 7d with balanced anti-oxidant and anti-dyslipidimic activities may be excellent candidates for lead optimization and drug development for the treatment of metabolic disorders., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2018
- Full Text
- View/download PDF